PDUFA VII: Will Gene Therapy's Rise Influence Talks?

The Center for Biologics Evaluation and Research may need more fee revenue to add employees to handle the increasing cell and gene therapy workload.

User Fee Reauthorization Preview 2020
Further co-mingling of funds between US FDA centers may be a topic of the upcoming PDUFA renewal talks. • Source: Pink Sheet illustration

More from Cell & Gene Therapies

More from Advanced Technologies